TGFB1 and liver failure: A common pathogenic cytokine, TGF-β, was found to suppress transcription of the gene, while BCAA antagonizes this suppression, suggesting a potential pharmacological significance of BCAA supplementation to the patients with hepatic failure that have defects in taurine metabolism.